Business
Expanded ATH434 Phase 2 Clinical Development Program
Expanded ATH434 Phase 2 Clinical Development Program
About this update from Alterity Therapeutics Ltd.
[{"type":"text","content":"Alterity Therapeutics Ltd has released a press release. View Attachment","length":247,"tagName":"div"}]